New York State Psychiatric Institute is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
New York State Psychiatric Institute has participated in 290 clinical trials with 21 currently active.
Therapeutic areas: Psychiatric Diagnosis, Marijuana Smoking, Dysthymic Disorder.
Sponsors: New York State Psychiatric Institute, Biohaven Pharmaceuticals, Inc., National Institute of Mental Health (NIMH).
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York State Psychiatric Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York State Psychiatric Institute has 290 clinical trials on record, with 21 currently active. Their work covers Psychiatric Diagnosis, Marijuana Smoking, Dysthymic Disorder.
New York State Psychiatric Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.